These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37610949)

  • 21. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of depression during the SARS, MERS, and COVID-19 pandemics: A protocol for overview of systematic reviews.
    Du L; Chen YM; Li Y; Yuan W; Wang JS
    Medicine (Baltimore); 2020 Sep; 99(38):e22235. PubMed ID: 32957366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological aspects of coronavirus disease during pregnancy: an integrative review.
    Silva CRACD; Oliveira LV; Lopes LP; Santos WAGD; Agra IKR
    Rev Assoc Med Bras (1992); 2020 May; 66(5):696-700. PubMed ID: 32638966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mast Cell's Role in Cytokine Release Syndrome and Related Manifestations of COVID-19 Disease.
    Özdemir Ö; Göksu Erol AY; Dikici Ü
    Curr Pharm Des; 2022; 28(40):3261-3268. PubMed ID: 36305137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 in pediatric cancer: a systematic review.
    Schlage S; Lehrnbecher T; Berner R; Simon A; Toepfner N
    Eur J Pediatr; 2022 Apr; 181(4):1413-1427. PubMed ID: 35006377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adaptive immunity to SARS-CoV-2 infection: A systematic review.
    Silva MJA; Ribeiro LR; Lima KVB; Lima LNGC
    Front Immunol; 2022; 13():1001198. PubMed ID: 36300105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID 19 repercussions in ophthalmology: a narrative review.
    Dos Santos Martins TG; Dos Santos Martins DG; Dos Santos Martins TG; Marinho P; Schor P
    Sao Paulo Med J; 2021; 139(5):535-542. PubMed ID: 34378743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome.
    Vita S; Di Bari V; Corpolongo A; Goletti D; Espinosa J; Petracca S; Palmieri F; Nicastri E;
    Int J Infect Dis; 2021 Feb; 103():607-610. PubMed ID: 33271290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms and mutations of ACE2 and TMPRSS2 genes are associated with COVID-19: a systematic review.
    Li J; Wang Y; Liu Y; Zhang Z; Zhai Y; Dai Y; Wu Z; Nie X; Du L
    Eur J Med Res; 2022 Feb; 27(1):26. PubMed ID: 35193695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is chlorhexidine mouthwash effective in lowering COVID-19 viral load? A systematic review.
    Rahman GS; Alshetan AAN; Alotaibi SSO; Alaskar BMI; Baseer MA
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(1):366-377. PubMed ID: 36647885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does SARS-CoV-2 Affect Male Urogenital System?
    Balawender K; Pliszka A; Krowiak A; Sito M; Grabarek BO; Boroń D
    Curr Pharm Biotechnol; 2022; 23(15):1792-1799. PubMed ID: 35255789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological and Hematological Response in COVID-19.
    Słomka A; Martucci G; Raffa GM; Malvindi PG; Żekanowska E; Lorusso R; Suwalski P; Kowalewski M
    Adv Exp Med Biol; 2021; 1352():73-86. PubMed ID: 35132595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurological Associations of SARS-CoV-2 Infection: A Systematic Review.
    Javed A
    CNS Neurol Disord Drug Targets; 2022; 21(3):246-258. PubMed ID: 33593267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current therapeutic options for coronavirus disease 2019 (COVID-19)-lessons learned from severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) therapy: a systematic review protocol.
    Zhang ZL; Zhong H; Liu YX; Le KJ; Cui M; Yu YT; Gu ZC; Gao Y; Lin HW
    Ann Transl Med; 2020 Nov; 8(22):1527. PubMed ID: 33313272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detailed study protocol for systematic scoping review of research on child marriage, 2000-2019.
    Greene ME; Siddiqi M
    BMJ Open; 2021 Mar; 11(3):e043845. PubMed ID: 33737433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-acute sequelae of SARS-CoV-2 infection (PASC): a protocol for a multidisciplinary prospective observational evaluation of a cohort of patients surviving hospitalisation in Sao Paulo, Brazil.
    Busatto GF; de Araújo AL; Duarte AJDS; Levin AS; Guedes BF; Kallas EG; Pinna FR; de Souza HP; da Silva KR; Sawamura MVY; Seelaender M; Imamura M; Garcia ML; Forlenza OV; Nitrini R; Damiano RF; Rocha VG; Batisttella LR; Carvalho CRR; ;
    BMJ Open; 2021 Jun; 11(6):e051706. PubMed ID: 34193506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus disease 2019 and pityriasis rosea: A review of the immunological connection.
    Borgia F; Li Pomi F; Alessandrello C; Vaccaro M; Pioggia G; Gangemi S
    J Dermatol; 2022 Oct; 49(10):948-956. PubMed ID: 35675487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.